Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance

Jonathan Edward Millar; Viktor von Bahr; Maximillian V Malfertheiner; Katrina K Ki; Meredith A Redd; Nicole Bartnikowski; Jacky Y Suen; Danny Francis McAuley; John F Fraser

doi:10.1136/thoraxjnl-2017-211439

Article info

Brief communication

Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance

Authors

Jonathan Edward Millar Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Viktor von Bahr Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care Medicine, Karolinska Institutet, Stockholm, Sweden PubMed articles Google scholar articles
Maximillian V Malfertheiner Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia Department of Internal Medicine II, Cardiology and Pneumology, University Medical Center Regensburg, Regensburg, Germany PubMed articles Google scholar articles
Katrina K Ki Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Meredith A Redd Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Nicole Bartnikowski Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Jacky Y Suen Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Danny Francis McAuley Queen’s University Belfast, Wellcome-Wolfson Centre for Experimental Medicine, Belfast, UK PubMed articles Google scholar articles
John F Fraser Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia PubMed articles Google scholar articles

Correspondence to Dr Jonathan Edward Millar, Critical Care Research Group, University of Queensland, The Prince Charles hospital, Brisbane QLD 4032, Australia ; j.millar{at}doctors.org.uk

View Full Text

Citation

Millar JE, von Bahr V, Malfertheiner MV, et al

Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance

Thorax 2019;74:194-196.

Publication history

Received December 18, 2017
Revised March 15, 2018
Accepted March 19, 2018
First published April 5, 2018.

Online issue publication

September 01, 2022

Article Versions

Previous version (15 January 2019).
Previous version (15 January 2019).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password